Investors Watch List: Lorillard (NYSE:LO), Synthetic Biologics Inc. (NYSEMKT:SYN), Tenneco Inc. (NYSE:TEN), VIVUS Inc. (NASDAQ:VVUS), Eli Lilly and Company (NYSE:LLY)


On Monday shares of Lorillard, Inc. (NYSE:LO) closed at $66.42. Company’s sales growth for last 5 years was 6.00% and EPS growth for next 5 years is recorded as 9.00%. A pivotal, possibly final, meeting between Reynolds American Inc. and Lorillard Inc (NYSE:LO) officials and federal regulators may take place this week, according to the Wall Street Journal. The meeting with Federal Trade Commission members could be the last step toward a decision on Reynolds’ $27.4 billion offer for Lorillard, which was announced July 15.

Synthetic Biologics Inc. (NYSEMKT:SYN) in last trading activity fell -1.29% to close at $2.29. Company weekly performance is -7.29% while its quarterly performance stands at 54.73%. Synthetic Biologics Inc. (NYSEMKT:SYN) is -27.87% away from its 52 week high. Synthetic Biologics, Inc. (NYSEMKT:SYN) announced the initiation of a Phase 2a clinical trial to evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, the Company’s investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent C. difficileinfection (CDI). C. difficile is the leading type of hospital acquired infection and is frequently associated with intravenous (IV) antibiotic treatment. Beta-lactam antibiotics are a mainstay in hospital infection management, and include commonly used penicillin and cephalosporin antibiotics, such as ceftriaxone.

On last trading day Tenneco Inc. (NYSE:TEN) advanced 1.70% to close at $56.80. Its volatility for the week is 1.68% while volatility for the month is 1.92%. TEN’s sales growth for past 5 years was 12.60% and its EPS growth for past 5 years was 34.70%. Tenneco Inc. (NYSE:TEN) monthly performance is -2.47%. Tenneco Inc. (NYSE:TEN) will participate in the Bank of America Merrill Lynch New York Auto Summit to be held on Wednesday, April 1, 2015. The webcasted presentation is scheduled to begin at 1:40 pm Eastern and run for 35 minutes. Tenneco’s Chairman and Chief Executive Officer, Gregg Sherrill, will present a general overview of the company and provide information regarding matters impacting the company’s outlook.

On Monday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $2.52. Company’s sales growth for last 5 years was 29.50% and EPS growth for next 5 years is recorded as 6.70%. VIVUS (NASDAQ:VVUS) announced an operational update, including certain key corporate decisions and plans regarding Qsymia (phentermine and topiramate extended-release) capsules CIV. These plans include further investments in high-value, consumer-focused digital media projects in support of obesity education and Qsymia, and focusing the Qsymia field sales organization of approximately 100 territories on the most productive target areas.

On last trading day Eli Lilly and Company (NYSE:LLY) advanced 0.39% to close at $73.87. Its volatility for the week is 1.54% while volatility for the month is 1.82%. LLY’s sales growth for past 5 years was -2.10% and its EPS growth for past 5 years was -10.80%. Eli Lilly and Company (NYSE:LLY) monthly performance is 5.27%. Eli Lilly and Company (NYSE:LLY) will conduct a meeting on June 7 to update the investment community and media on the company’s diabetes business. The discussion, being held in conjunction with the 75th American Diabetes Association® Scientific Sessions, will include multiple topics related to the company’s diabetes business, including a review of the Phase III data for basal insulin peglispro that will be presented during the ADA meeting.


Leave a Reply

Your email address will not be published. Required fields are marked *